# Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism

> **NCT00759070** · PHASE4 · UNKNOWN · sponsor: **Juan A. Arnaiz** · enrollment: 50 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tenofovir + emtricitabine + efavirenz
- **DRUG:** Tenofovir + emtricitabine + lopinavir/ritonavir

## Key facts

- **NCT ID:** NCT00759070
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-02-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759070, "Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00759070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*